These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29408457)

  • 41. Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells.
    Omori Y; Kitamura T; Yoshida S; Kuwahara R; Chaya T; Irie S; Furukawa T
    Genes Cells; 2015 May; 20(5):408-26. PubMed ID: 25757744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MEF2D overexpression contributes to the progression of osteosarcoma.
    Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
    Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MEF2D Functions as a Tumor Suppressor in Breast Cancer.
    Wang X; Shen H; Chen Y; Zhang Y; Wang J; Liu S; Xu B; Wang H; Frangou C; Zhang J
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts.
    Fuka G; Kantner HP; Grausenburger R; Inthal A; Bauer E; Krapf G; Kaindl U; Kauer M; Dworzak MN; Stoiber D; Haas OA; Panzer-Grümayer R
    Leukemia; 2012 May; 26(5):927-33. PubMed ID: 22094587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia.
    Chang N; Feng J; Liao P; Hu Y; Li M; He Y; Li Y
    Transl Cancer Res; 2023 Feb; 12(2):287-300. PubMed ID: 36915581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci.
    de Bruijn DR; Geurts van Kessel A
    Cytogenet Genome Res; 2006; 112(3-4):222-6. PubMed ID: 16484776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
    Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
    Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements.
    Cao HY; Li HY; Cai WZ; Huang YH; Qiu QC; Li Z; Xu Y; Xue SL; Dai HP
    Ann Hematol; 2024 Jul; ():. PubMed ID: 38990294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
    Xu K; Zhao YC
    Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
    Put N; Deeren D; Michaux L; Vandenberghe P
    Cancer Genet; 2011 Aug; 204(8):462-4. PubMed ID: 21962897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
    Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D.
    Li M; Liu Z; Zhang Z; Liu G; Sun S; Sun C
    Biol Chem; 2015 Mar; 396(3):235-44. PubMed ID: 25400071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
    Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
    Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
    Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
    Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
    Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia.
    Zhang H; Meng G
    Blood Sci; 2022 Jul; 4(3):161-163. PubMed ID: 36518591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SS18 regulates pluripotent-somatic transition through phase separation.
    Kuang J; Zhai Z; Li P; Shi R; Guo W; Yao Y; Guo J; Zhao G; He J; Xu S; Wu C; Yu S; Zhou C; Wu L; Qin Y; Cai B; Li W; Wu Z; Li X; Chu S; Yang T; Wang B; Cao S; Li D; Zhang X; Chen J; Liu J; Pei D
    Nat Commun; 2021 Jul; 12(1):4090. PubMed ID: 34215745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.
    Ohki K; Butler ER; Kiyokawa N; Hirabayashi S; Bergmann AK; Möricke A; Boer JM; Cavé H; Cazzaniga G; Yeoh AEJ; Sanada M; Imamura T; Inaba H; Mullighan CG; Loh ML; Norén-Nyström U; Shih LY; Zaliova M; Pui CH; Haas OA; Harrison CJ; Moorman AV; Manabe A
    Leukemia; 2023 Jan; 37(1):212-216. PubMed ID: 36309560
    [No Abstract]   [Full Text] [Related]  

  • 60. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
    Shojaee S; Caeser R; Buchner M; Park E; Swaminathan S; Hurtz C; Geng H; Chan LN; Klemm L; Hofmann WK; Qiu YH; Zhang N; Coombes KR; Paietta E; Molkentin J; Koeffler HP; Willman CL; Hunger SP; Melnick A; Kornblau SM; Müschen M
    Cancer Cell; 2015 Jul; 28(1):114-28. PubMed ID: 26073130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.